Insider Transactions in Q1 2024 at Amgen Inc (AMGN)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 18
2024
|
Derek Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
475
-5.34%
|
$127,300
$268.87 P/Share
|
Mar 18
2024
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,202
-9.28%
|
$1,662,136
$268.87 P/Share
|
Mar 18
2024
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
6,137
-8.04%
|
$1,644,716
$268.87 P/Share
|
Mar 18
2024
|
Peter H. Griffith EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,168
-12.96%
|
$1,385,024
$268.87 P/Share
|
Mar 18
2024
|
Nancy A. Grygiel SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-5.44%
|
$188,404
$268.87 P/Share
|
Mar 18
2024
|
Rachna Khosla SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
438
-5.08%
|
$117,384
$268.87 P/Share
|
Mar 18
2024
|
Murdo Gordon EVP, Global Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
6,461
-11.18%
|
$1,731,548
$268.87 P/Share
|
Mar 18
2024
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,879
-14.66%
|
$1,575,572
$268.87 P/Share
|
Mar 18
2024
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
20,560
-3.0%
|
$5,510,080
$268.87 P/Share
|
Mar 18
2024
|
Matthew C. Busch VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-3.03%
|
$39,128
$268.87 P/Share
|
Mar 06
2024
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
12,278
+13.89%
|
-
|
Mar 06
2024
|
Rachna Khosla SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,256
+12.75%
|
-
|
Mar 06
2024
|
Derek Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,311
+12.89%
|
-
|
Mar 06
2024
|
David M Reese EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,407
+15.69%
|
-
|
Mar 06
2024
|
Murdo Gordon EVP, Global Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
12,924
+18.33%
|
-
|
Mar 06
2024
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
11,760
+22.75%
|
-
|
Mar 06
2024
|
Peter H. Griffith EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,338
+20.85%
|
-
|
Mar 06
2024
|
Nancy A. Grygiel SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,954
+13.18%
|
-
|
Mar 06
2024
|
Robert A Bradway Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
41,133
+5.67%
|
-
|
Mar 06
2024
|
Matthew C. Busch VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
418
+8.01%
|
-
|
Feb 09
2024
|
James E. Bradner EVP, R&D, & Chief Sci. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,393
+44.07%
|
-
|